Advantage Alpha Capital Partners’s MiMedx Group MDXG Stock Holding History

Advantage Alpha Capital Partners’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-56,727	Closed	-$396K	–	72
2025 Q3	$396K	Sell	56,727 -9,397	-14%	-$65.3K	0.12%	113
2025 Q2	$403K	Sell	66,124 -15,505	-19%	-$103K	0.11%	104
2025 Q1	$620K	Buy	81,629 +28,342	+53%	+$237K	0.15%	96
2024 Q4	$512K	Sell	53,287 -29,596	-36%	-$231K	0.12%	132
2024 Q3	$491K	Sell	82,883 -43,709	-35%	-$290K	0.11%	129
2024 Q2	$877K	Sell	126,592 -13,301	-10%	-$93.5K	0.19%	88
2024 Q1	$1.08M	Sell	139,893 -17,812	-11%	-$143K	0.2%	98
2023 Q4	$1.38M	Buy	+157,705	New	+$1.15M	0.26%	92

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Advantage Alpha Capital Partners's MDXG Position: Q4 2025 in Review

Advantage Alpha Capital Partners sold out of MiMedx Group (MDXG) in Q4 2025, closing a stake of 56,727 shares — an estimated $396K sold.

Advantage Alpha Capital Partners first reported a position in MDXG in Q4 2023 and held it in 8 quarters. The position peaked at $1.38M in Q4 2023. 233 funds tracked by Wall St. Rank hold MDXG as of Q4 2025.

Advantage Alpha Capital Partners reported no remaining MiMedx Group position as of Q4 2025 after selling out during the quarter.
Advantage Alpha Capital Partners sold 56,727 MiMedx Group shares in Q4 2025, an estimated $396K.
Advantage Alpha Capital Partners first reported a position in MiMedx Group in Q4 2023 and held it in 8 quarters.
Advantage Alpha Capital Partners's MiMedx Group position peaked at $1.38M in Q4 2023.
233 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2025.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2025.